Search results for "Randomized"

showing 10 items of 2323 documents

Radiotherapy before or during androgen-deprivation therapy does not blunt the exercise-induced body composition protective effects in prostate cancer…

2021

Background Androgen deprivation therapy (ADT) contributes to lean mass loss and adiposity increases in prostate cancer patients. Radiotherapy during ADT might act synergistically and further worsen body composition. Previous investigations have shown that resistance training is an effective method of preserving body composition during ADT, however, most have not accounted for direct or indirect effects of other therapies, such as radiotherapy. Therefore, the purpose of this study was to examine training adaptations of the tissue composition in patients receiving radiation therapy (RT) prior or during ADT. Methods Analyses were performed by combining data from two previous trials for a total…

Male0301 basic medicineAgingmedicine.medical_treatmentBiochemistryMuscle hypertrophylaw.inventionAndrogen deprivation therapyProstate cancer0302 clinical medicineEndocrinologyRandomized controlled triallawRandomized Controlled Trials as Topicadipositykuntoliikuntamuscle massAndrogensBody Compositionhypertrophyliikuntahoitomedicine.medical_specialtyUrology03 medical and health sciencesAtrophyatrophyGeneticsmedicineHumansAerobic exerciseMuscle StrengthMolecular BiologyatrofiaAgedkehonkoostumussyöpähoidotbusiness.industryProstatic NeoplasmsAndrogen AntagonistsCell Biologymedicine.diseaseRadiation therapysädehoito030104 developmental biologyresistance exerciselihasmassaLean body massbusinesslihassurkastumasairaudet030217 neurology & neurosurgery
researchProduct

Replacing red meat and processed red meat for white meat, fish, legumes or eggs is associated with lower risk of incidence of metabolic syndrome.

2016

BACKGROUND & AIMS: Few studies have assessed the association between consumption of red meat (RM) and processed red meats (PRM) and the incidence of metabolic syndrome (MetS) and results have been inconsistent. We investigated associations between total consumption of meat and its subtypes and incident MetS and estimated the effect of substituting RM or PRM for alternative protein-rich foods. METHODS: We analyzed 1868 participants (55-80 years-old) recruited into the PREDIMED study who had no MetS at baseline and were followed for a median of 3.2 years. MetS was defined using updated harmonized criteria. Anthropometric variables, dietary habits, and blood biochemistry were determined at bas…

Male0301 basic medicineCarn -- Aspectes nutricionalsSíndrome metabòlicaMeatMediterranean dietWhite meatEggsPREDIMED-study030209 endocrinology & metabolismCritical Care and Intensive Care MedicineLower risk03 medical and health sciencesProcessed red meat0302 clinical medicineRisk FactorsTotal meatmedicineAnimalsHumansLongitudinal StudiesFood scienceAgedProportional Hazards ModelsRandomized Controlled Trials as TopicAged 80 and overMetabolic SyndromeRed meat030109 nutrition & dieteticsNutrition and Dieteticsbusiness.industryIncidenceIncidence (epidemiology)Hazard ratioFishesFabaceaeMiddle Agedmedicine.diseaseConfidence intervalRed MeatNutrition AssessmentSeafoodRed meatFemaleDiet HealthyMetabolic syndromebusinessFollow-Up Studies
researchProduct

High perceived stress is associated with unfavorable eating behavior in overweight and obese Finns of working age

2016

Stress-related eating may be a potential factor in the obesity epidemic. Rather little is known about how stress associates with eating behavior and food intake in overweight individuals in a free-living situation. Thus, the present study aims to investigate this question in psychologically distressed overweight and obese working-aged Finns. The study is a cross-sectional baseline analysis of a randomized controlled trial. Of the 339 study participants, those with all the needed data available (n = 297, 84% females) were included. The mean age was 48.9 y (SD = 7.6) and mean body mass index 31.3 kg/m(2) (SD = 3.0). Perceived stress and eating behavior were assessed by self-reported questionn…

Male0301 basic medicineFOOD-INTAKEobesityEmotionsPerceived Stress ScaleOverweighteating behaviorBody Mass IndexDevelopmental psychologyEatingRisk FactorsWeight managementFinlandGeneral Psychologyta515Randomized Controlled Trials as TopicMETABOLIC SYNDROME2. Zero hungerGENERAL-POPULATIONNutrition and DieteticsIntuitive eatingta3141Middle AgedEmotional eating3. Good healthDEPRESSIVE SYMPTOMS/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingFemaleHEALTHmedicine.symptomPsychologyClinical psychologyAdultta222Alcohol Drinking515 Psychologyperceived stressDIET QUALITYta311103 medical and health sciencesSDG 3 - Good Health and Well-beingCOMPETENCE INVENTORYDRINKINGmedicineHumans030109 nutrition & dieteticsemotional eatingFeeding BehaviorOverweightmedicine.diseaseintuitive eatingObesityBODY-MASS INDEX3141 Health care scienceCross-Sectional StudiesPSYCHOMETRIC PROPERTIESlihavuusSelf ReportMetabolic syndromedietary intakeBody mass indexStress PsychologicalAppetite
researchProduct

Predictors of short- and long-term adherence with a Mediterranean-type diet intervention: the PREDIMED randomized trial.

2016

Background: Dietary intervention success requires strong participant adherence, but very few studies have examined factors related to both short-term and long-term adherence. A better understanding of predictors of adherence is necessary to improve the design and execution of dietary intervention trials. This study was designed to identify participant characteristics at baseline and study features that predict short-term and long-term adherence with interventions promoting the Mediterranean-type diet (MedDiet) in the PREvencion con DIeta MEDiterranea (PREDIMED) randomized trial. Methods: Analyses included men and women living in Spain aged 55-80 at high risk for cardiovascular disease. Part…

Male0301 basic medicineGerontologymodelos logísticoscumplimiento del pacienteMediterranean dietHealth BehaviorhumanosPsychological interventionMedicine (miscellaneous)ejercicio físicoDietary predictorsDiet MediterraneanLogistic regressionDieta mediterrànialaw.invention0302 clinical medicine1479-5868Randomized controlled trialRisk FactorslawNuts030212 general & internal medicineconducta sanitariaDietary adherencemediana edadDietoteràpiaancianoBioquímica y tecnologíaNutrition and DieteticsdietaHàbits alimentarisMiddle AgedBiochemistry and technologyCardiovascular DiseasesFemaleDietaWaist Circumferencemedicine.medical_specialtyWaistFood habitsPromoció de la salutenfermedades cardiovascularesPhysical Therapy Sports Therapy and RehabilitationHealth PromotionClinical nutrition:Ciencias de la Salud::Nutrición y dietética [Materias Investigacion]Bioquímica i biotecnologiaShort-term dietary adherence03 medical and health sciencesMediterranean cookingdietary interventionMediterranean dietCuina mediterràniaingesta energéticamedicineHumansfactores de riesgoAdverse effectOlive OilExerciseDieta -- Mediterrània Regió de laAgedconducta alimentaria030109 nutrition & dieteticsperímetro abdominalMediterranean Dietbusiness.industryResearchFeeding BehaviorDietPREDIMED trialnuecesDietary interventionLogistic ModelsHealth promotionSpainPhysical therapyLong-term dietary adherencePatient ComplianceHealth promotionEnergy Intakebusiness:Ciencias de la Salud::Endocrinología [Materias Investigacion]
researchProduct

Mediterranean Diet and atherothrombosis biomarkers: a randomized controlled trial

2020

Scope To assess whether following a Mediterranean diet (MedDiet) improves atherothrombosis biomarkers in high cardiovascular risk individuals. Methods and results In 358 random volunteers from the PREvención con DIeta MEDiterránea trial, the 1‐year effects on atherothrombosis markers of an intervention with MedDiet, enriched with virgin olive oil (MedDiet‐VOO; n = 120) or nuts (MedDiet‐Nuts; n = 119) versus a low‐fat control diet (n = 119), and whether large increments in MedDiet adherence (≥3 score points, versus compliance decreases) and intake changes in key food items are associated with 1‐year differences in biomarkers. Differences are observed between 1‐year changes in the MedDiet‐VOO…

Male0301 basic medicineMediterranean dietProcessed meat intakeAtherothrombosisDiet MediterraneanFibrinogenGastroenterologyCardiovascular riskslaw.inventionFood groupEatingchemistry.chemical_compoundClinical trialsRandomized controlled triallawPlateletNitriteAged 80 and overchemistry.chemical_classificationAntithrombinMiddle AgedThrombosisCardiovascular diseasesBiomarker (medicine)FemaleDietaLipoproteins HDLBiotechnologymedicine.drugcardiovascular riskmedicine.medical_specialty03 medical and health sciencesFatty fishMediterranean cookingThrombinMediterranean dietInternal medicineCuina mediterràniamedicineHumansOlive OilAged030109 nutrition & dieteticsMalalties cardiovascularsbusiness.industryFatty acidThrombosisAtherosclerosismedicine.diseaseConfidence intervalDietCross-Sectional Studies030104 developmental biologyEndocrinologychemistryalpha 1-AntitrypsinbusinessBiomarkersFood Science
researchProduct

Mediterranean Diet Maintained Platelet Count within a Healthy Range and Decreased Thrombocytopenia-Related Mortality Risk: A Randomized Controlled Tr…

2021

There is little information on the dietary modulation of thrombosis-related risk factors such as platelet count. We aimed to assess the effects of Mediterranean diet (MedDiet) on platelet count and related outcomes in an older population at high cardiovascular risk. In participants of the PREDIMED (PREvención con DIeta MEDiterránea) study, we assessed whether an intervention with a MedDiet enriched with extra-virgin olive oil or nuts, relative to a low-fat control diet, modulated platelet count (n = 4189), the risk of developing thrombocytosis and thrombocytopenia (n = 3086), and the association between these alterations and all-cause mortality (median follow-up time: 3.0 years). Although p…

Male0301 basic medicineMediterranean dietthrombocytopenia030204 cardiovascular system & hematologyDiet Mediterraneanlaw.inventionClinical trials0302 clinical medicinepreventionRandomized controlled triallawPlateletThrombocytosisNutrition and DieteticsFactors de risc en les malaltiesIncidenceIncidence (epidemiology)Hazard ratioFemaleDietalcsh:Nutrition. Foods and food supplymedicine.medical_specialtyRisk factors in diseaseslcsh:TX341-641ArticleOlder population03 medical and health sciencesMediterranean cookingMediterranean dietInternal medicineCuina mediterràniamedicineHumansAgedProportional Hazards ModelsThrombocytosisPlatelet Countbusiness.industryplatelet countmedicine.diseaseConfidence intervalDiet030104 developmental biologyHeart Disease Risk Factorsrandomized controlled trialbusinessAssaigs clínicsFood ScienceNutrients
researchProduct

Efficacy of trifluridine and tipiracil (TAS-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic …

2016

[Purpose] TAS-102 is a combination of the thymidine-based nucleoside analog trifluridine and the thymidine phosphorylase inhibitor tipiracil. Efficacy and safety of TAS-102 in patients with metastatic colorectal cancer (mCRC) refractory or intolerant to standard therapies were evaluated in the phase 3 RECOURSE trial. Results of RECOURSE demonstrated significant improvement in overall survival (OS) and progression-free survival (PFS) with TAS-102 versus placebo [hazard ratio (HR) = 0.68 and 0.48 for OS and PFS, respectively; both P < 0.001]. The current analysis evaluates efficacy and safety of TAS-102 in the RECOURSE Spanish subgroup.

Male0301 basic medicineOncologyCancer ResearchPyrrolidinesColorectal cancerTrifluridineHelsinki declarationlaw.inventionTrifluridinechemistry.chemical_compound0302 clinical medicineRandomized controlled triallawMedicineAged 80 and overMetastatic colorectal cancerPalliative CareHazard ratioGeneral MedicineMiddle AgedPrognosisTAS-102Survival RateDrug CombinationsOncology030220 oncology & carcinogenesisDrug Therapy CombinationFemaleColorectal NeoplasmsFluoropyrimidineResearch Articlemedicine.drugAdultmedicine.medical_specialtyanimal structuresSubgroup analysisPlaceboAntiviral Agents03 medical and health sciencesDouble-Blind MethodInternal medicineHumansTipiracil hydrochlorideUracilAgedNeoplasm StagingTipiracilbusiness.industrymedicine.diseaseSurgery030104 developmental biologychemistrySpainbusinessThymineFollow-Up StudiesClinical and Translational Oncology
researchProduct

Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR…

2017

BACKGROUND: There is increasing evidence that metastatic colorectal cancer (mCRC) is a genetically heterogeneous disease and that tumours arising from different sides of the colon (left versus right) have different clinical outcomes. Furthermore, previous analyses comparing the activity of different classes of targeted agents in patients with KRAS wild-type (wt) or RAS wt mCRC suggest that primary tumour location (side), might be both prognostic and predictive for clinical outcome. METHODS: This retrospective analysis investigated the prognostic and predictive influence of the localization of the primary tumour in patients with unresectable RAS wt mCRC included in six randomized trials (CRY…

Male0301 basic medicineOncologyColorectal cancermedicine.medical_treatmentCetuximabmedicine.disease_causeEGFR Antibody0302 clinical medicineAntineoplastic Agents ImmunologicalNeoplasias ColorrectaisMedicineNeoplasm MetastasisRandomized Controlled Trials as Topicpredictive valuePanitumumabHazard ratiotumour sideAntibodies MonoclonalHematologyPrognosisChemotherapy regimenErbB ReceptorsBevacizumabTreatment OutcomeOncology030220 oncology & carcinogenesisFemaleKRASColorectal Neoplasmsmedicine.drugmedicine.medical_specialtyBevacizumabcolorectal cancerGenes ras03 medical and health sciencesAnticorpos MonoclonaisInternal medicineHumansChemotherapybusiness.industryAntineoplásicos ImunológicosOdds ratiomedicine.diseaserandomised trial030104 developmental biologyGenes rasHuman medicinebusinessprognosticanti-EGFR treatment
researchProduct

Session 2: Are we ready for primary chemotherapy in rectal cancer: who, when, why?

2018

The potential of preoperative chemotherapy in rectal cancer is the subject of investigation in a number of global randomized trials. In this overview and expert discussion, Professor Cervantes summarizes the findings of numerous Phase II trials testing neoadjuvant chemotherapy. The crucial points in the next phase of trials include: patient selection, whether radiotherapy can be omitted altogether and whether chemotherapy can be used to augment the initial response to chemoradiotherapy. Finally, with the emergence of Magnetic Resonance Tumour Regression Grade a reliable method for assessing response after initial chemoradiotherapy, we ask if this can be used to drive the use of further sele…

Male0301 basic medicineOncologymedicine.medical_specialtyConsensusColorectal cancermedicine.medical_treatmentRisk AssessmentDisease-Free SurvivalSession (web analytics)law.invention03 medical and health sciencesClinical Trials Phase II as Topic0302 clinical medicineRandomized controlled triallawInternal medicineAntineoplastic Combined Chemotherapy ProtocolsPreoperative CaremedicineHumansPreoperative chemotherapyChemotherapyProctectomyRectal Neoplasmsbusiness.industryGastroenterologyPrognosismedicine.diseaseMagnetic Resonance ImagingSurvival AnalysisNeoadjuvant TherapyRadiation therapyTreatment Outcome030104 developmental biology030220 oncology & carcinogenesisFemaleAugmentbusinessChemoradiotherapyColorectal Disease
researchProduct

Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study

2017

Background: The role of polyphenol intake on cardiovascular risk factors is little explored, particularly in people with diabetes. Aim: To evaluate the association between the intake of total polyphenols and polyphenol classes with the major cardiovascular risk factors in a population with type 2 diabetes. Methods: Dietary habits were investigated in 2573 males and females participants of the TOSCA.IT study. The European Prospective Investigation on Cancer and Nutrition (EPIC) questionnaire was used to assess dietary habits. In all participants, among others, we assessed anthropometry, plasma lipids, blood pressure, C-reactive protein and HbA1c following a standard protocol. The USDA and Ph…

Male0301 basic medicinePhysiologyType 2 diabetes030204 cardiovascular system & hematologyCritical Care and Intensive Care MedicineSettore MED/13 - Endocrinologiachemistry.chemical_compound0302 clinical medicineDietary polyphenolsFlavonoidsPhenolic acidsCardiovascular riskType 2 diabetesLOW-GRADE INFLAMMATIONBLOOD-PRESSUREDIETARY POLYPHENOLSDARK CHOCOLATEINSULIN SENSITIVITYRANDOMIZED-TRIALSDISEASEMETAANALYSISMETABOLISMCHOLESTEROLRisk FactorsSurveys and QuestionnairesHydroxybenzoatesProspective StudiesFood scienceCardiovascular risk; Dietary polyphenols; Flavonoids; Phenolic acids; Type 2 diabeteseducation.field_of_studyPhenolic acidNutrition and Dieteticsbiologyfood and beveragesType 2 diabetesDietary polyphenolMiddle AgedDietary polyphenols; Flavonoids; Phenolic acids; Cardiovascular risk; Type 2 diabetesEuropean Prospective Investigation into Cancer and NutritionDietary polyphenolsCardiovascular DiseasesFemalePhenolic acidsPopulationCardiovascular risk Dietary polyphenols Flavonoids Phenolic acids Type 2 diabetes03 medical and health sciencesDiabetes mellitusmedicineHumanseducationTriglyceridesAgedFlavonoids030109 nutrition & dieteticsDose-Response Relationship Drugbusiness.industryCholesterol HDLC-reactive proteinPolyphenolsCholesterol LDLAnthropometrymedicine.diseaseCardiovascular riskCardiovascular risk; Dietary polyphenols; Flavonoids; Phenolic acids; Type 2 diabetes; Nutrition and Dietetics; Critical Care and Intensive Care MedicineDietCross-Sectional StudiesNutrition AssessmentDiabetes Mellitus Type 2chemistryFlavonoidbiology.proteinGlycated hemoglobinbusinessBody mass index
researchProduct